Robert Rhodes, MD
Otolaryngology · Oklahoma City, OKNPI 1609254374
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,212 of the $1,473 with a category attached, or 82.3%. 10 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.1% of the total. 2025 is the largest year on record at $326, 2.6 times the $124 reported in 2019.
Across 15 payments — averaging $98.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$356
- Medtronic$291
- Stryker$261
- Integra Lifesciences Corporation$168
- Axogen$128
- Paratek Pharmaceuticals, Inc.$116
- plus $153 from 4 others
What the payments were for
- Food & beverage$1,21282%
- Education$26118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $356 |
| Medtronic(2 entities) | 2 | $291 |
| Stryker | 1 | $261 |
| Integra Lifesciences Corporation | 1 | $168 |
| Axogen | 1 | $128 |
| Paratek Pharmaceuticals, Inc. | 1 | $116 |
| AbbVie | 2 | $84 |
| Organogenesis Inc. | 2 | $33 |
| Stimlabs LLC | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$356
- UNIVERSAL MANDIBLE$261
- Acclarent Aera$168
- Inspira Air$168
- RELIEVA SPINPLUS NAV$168
- TruDi Probe$168
- PROPEL$166
- AVANCE NERVE GRAFT$128
- AxoGuard Nerve Connector$128
- AxoGuard Nerve Protector$128
- AXOGUARD HA+ NERVE PROTECTOR$128
- AxoGuard Nerve Cap$128
- FUSION$124
- NUZYRA$116
How this compares
$1,473 in reported general payments places this provider in the 55th percentile of 109 otolaryngology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 134 | $1,828 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $1,062 |
| Clindamycin Hcl | 214 | $433 |
| Promethazine Hcl | 111 | $228 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $147 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Oklahoma City
- Kibwei McKinneyOklahoma City$315K
- Richard BakerOklahoma City$17K
- Edward El RassiOklahoma City$13K
- Benjamin CollinsOklahoma City$10K
- Keith ClarkOklahoma City$6K
- Rachad MhawejOklahoma City$6K
- John HouckOklahoma City$5K
- Matthew SharumOklahoma City$5K
- Hassan HawsawiOklahoma City$5K
- Brandon PiersonOklahoma City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.